CA2266425A1 - Genes 2 et 3 de translocation de lymphocytes b humains - Google Patents

Genes 2 et 3 de translocation de lymphocytes b humains Download PDF

Info

Publication number
CA2266425A1
CA2266425A1 CA002266425A CA2266425A CA2266425A1 CA 2266425 A1 CA2266425 A1 CA 2266425A1 CA 002266425 A CA002266425 A CA 002266425A CA 2266425 A CA2266425 A CA 2266425A CA 2266425 A1 CA2266425 A1 CA 2266425A1
Authority
CA
Canada
Prior art keywords
btg
polypeptide
amino acid
seq
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002266425A
Other languages
English (en)
Inventor
Charles A. Kunsch
Arvind Chopra
Craig A. Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2266425A1 publication Critical patent/CA2266425A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux gènes antiproliférateurs, plus particulièrement des molécules d'acide nucléique isolées codant les gènes 2 et 3 de translocation des lymphocytes B humains (BTG-2 et BTG-3). Elle concerne également des polypeptides de BTG-2 et de BTG-3, ainsi que des vecteurs, des cellules hôtes et des méthodes de recombinaison permettant de produire lesdits gènes.
CA002266425A 1996-09-18 1996-09-18 Genes 2 et 3 de translocation de lymphocytes b humains Abandoned CA2266425A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/014997 WO1998012204A1 (fr) 1996-09-18 1996-09-18 Genes 2 et 3 de translocation de lymphocytes b humains

Publications (1)

Publication Number Publication Date
CA2266425A1 true CA2266425A1 (fr) 1998-03-26

Family

ID=22255815

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002266425A Abandoned CA2266425A1 (fr) 1996-09-18 1996-09-18 Genes 2 et 3 de translocation de lymphocytes b humains

Country Status (5)

Country Link
EP (1) EP0948515A4 (fr)
JP (1) JP2001501464A (fr)
AU (1) AU7364596A (fr)
CA (1) CA2266425A1 (fr)
WO (1) WO1998012204A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1160119C (zh) * 2001-02-27 2004-08-04 中国科学院上海生物化学研究所 Tob基因在哺乳动物中枢神经系统的功能及其应用
FR2827773A1 (fr) * 2001-07-30 2003-01-31 Inst Necker Composition pour la regulation negative de l'activite tyrosine kinase des proteines src et analogues, et applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2101195A (en) * 1995-03-17 1996-10-08 Human Genome Sciences, Inc. Human b-cell translocation genes-2 and 3

Also Published As

Publication number Publication date
EP0948515A4 (fr) 2003-01-02
AU7364596A (en) 1998-04-14
WO1998012204A1 (fr) 1998-03-26
JP2001501464A (ja) 2001-02-06
EP0948515A1 (fr) 1999-10-13

Similar Documents

Publication Publication Date Title
US8017349B2 (en) Human neuronal attachment factor-1
US20070154908A1 (en) Connective Tissue Growth Factor-2
CA2210444C (fr) Facteur-2 de croissance des keratinocytes
US7153827B1 (en) Vascular endothelial growth factor 2 and methods of use
US5710024A (en) Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44)
WO1996035703A1 (fr) Inhibiteur humain du gene 1 de l'apoptose
US6537539B2 (en) Immune cell cytokine
WO1996039424A1 (fr) Facteur c stimulant les cellules tueuses naturelles
US7083930B2 (en) Human choline acetyltransferase
WO1997029189A1 (fr) Facteur 1 de fixation neuronale humain
US20030022312A1 (en) Human hepatoma-derived growth factor-2
US7049081B2 (en) Diagnostic methods based on human BTG-2 and BTG-3 polypeptides
CA2266425A1 (fr) Genes 2 et 3 de translocation de lymphocytes b humains
WO1998012204A9 (fr) Genes 2 et 3 de translocation de lymphocytes b humains
AU716100B2 (en) Human vascular endothelial growth factor 3
US5798223A (en) Polynucleotides encoding human amine transporter and methods of using the same
US5962268A (en) DNA encoding an immune cell cytokine
AU762694B2 (en) Human criptin growth factor
WO1997025338A1 (fr) Cytokine de cellule immunitaire
EP0873349A1 (fr) Polypeptide de type iii activateur des monocytes et des cellules endotheliales
AU2780600A (en) Human vascular endothelial growth factor 3
AU2003252757A1 (en) Human Criptin Growth Factor

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead